These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 27222100)
61. Novel functional interactions between Trk kinase and p75 neurotrophin receptor in neuroblastoma cells. Lachyankar MB; Condon PJ; Daou MC; De AK; Levine JB; Obermeier A; Ross AH J Neurosci Res; 2003 Jan; 71(2):157-72. PubMed ID: 12503079 [TBL] [Abstract][Full Text] [Related]
62. Detection of NGF-receptors TrkA and p75NTR in human tumor cell lines and effect of NGF on the growth characteristic of the UT-7/EPO cell line. Westphal G; van den Berg-Stein S; Braun K; Knoch TA; Dümmerling M; Langowski J; Debus J; Friedrich E J Exp Clin Cancer Res; 2002 Jun; 21(2):255-67. PubMed ID: 12148587 [TBL] [Abstract][Full Text] [Related]
63. The p75 neurotrophin receptor mediates neuronal apoptosis and is essential for naturally occurring sympathetic neuron death. Bamji SX; Majdan M; Pozniak CD; Belliveau DJ; Aloyz R; Kohn J; Causing CG; Miller FD J Cell Biol; 1998 Feb; 140(4):911-23. PubMed ID: 9472042 [TBL] [Abstract][Full Text] [Related]
64. Spatio-temporal expression profile of NGF and the two-receptor system, TrkA and p75NTR, in experimental autoimmune encephalomyelitis. Delivanoglou N; Boziki M; Theotokis P; Kesidou E; Touloumi O; Dafi N; Nousiopoulou E; Lagoudaki R; Grigoriadis N; Charalampopoulos I; Simeonidou C J Neuroinflammation; 2020 Jan; 17(1):41. PubMed ID: 31996225 [TBL] [Abstract][Full Text] [Related]
65. A novel PI3K inhibitor displays potent preclinical activity against an androgen-independent and PTEN-deficient prostate cancer model established from the cell line PC3. Shi M; Zhou X; Zhang Z; Wang M; Chen G; Han K; Cao B; Liu Z; Mao X Toxicol Lett; 2014 Aug; 228(3):133-9. PubMed ID: 24831963 [TBL] [Abstract][Full Text] [Related]
66. Restoration of insulin-like growth factor binding protein-related protein 1 has a tumor-suppressive activity through induction of apoptosis in human prostate cancer. Mutaguchi K; Yasumoto H; Mita K; Matsubara A; Shiina H; Igawa M; Dahiya R; Usui T Cancer Res; 2003 Nov; 63(22):7717-23. PubMed ID: 14633696 [TBL] [Abstract][Full Text] [Related]
67. NGF activates the phosphorylation of MAP1B by GSK3beta through the TrkA receptor and not the p75(NTR) receptor. Goold RG; Gordon-Weeks PR J Neurochem; 2003 Nov; 87(4):935-46. PubMed ID: 14622124 [TBL] [Abstract][Full Text] [Related]
69. Blocking Nerve Growth Factor Signaling Reduces the Neural Invasion Potential of Pancreatic Cancer Cells. Bapat AA; Munoz RM; Von Hoff DD; Han H PLoS One; 2016; 11(10):e0165586. PubMed ID: 27792755 [TBL] [Abstract][Full Text] [Related]
70. R115777 (Zarnestra)/Zoledronic acid (Zometa) cooperation on inhibition of prostate cancer proliferation is paralleled by Erk/Akt inactivation and reduced Bcl-2 and bad phosphorylation. Caraglia M; Marra M; Leonetti C; Meo G; D'Alessandro AM; Baldi A; Santini D; Tonini G; Bertieri R; Zupi G; Budillon A; Abbruzzese A J Cell Physiol; 2007 May; 211(2):533-43. PubMed ID: 17192846 [TBL] [Abstract][Full Text] [Related]
71. A novel synthetic protoapigenone analogue, WYC02-9, induces DNA damage and apoptosis in DU145 prostate cancer cells through generation of reactive oxygen species. Chen HM; Chang FR; Hsieh YC; Cheng YJ; Hsieh KC; Tsai LM; Lin AS; Wu YC; Yuan SS Free Radic Biol Med; 2011 May; 50(9):1151-62. PubMed ID: 21256211 [TBL] [Abstract][Full Text] [Related]
72. Suppression of telomerase, reexpression of KAI1, and abrogation of tumorigenicity by nerve growth factor in prostate cancer cell lines. Sigala S; Faraoni I; Botticini D; Paez-Pereda M; Missale C; Bonmassar E; Spano P Clin Cancer Res; 1999 May; 5(5):1211-8. PubMed ID: 10353759 [TBL] [Abstract][Full Text] [Related]
73. A novel p75 neurotrophin receptor-related protein, NRH2, regulates nerve growth factor binding to the TrkA receptor. Murray SS; Perez P; Lee R; Hempstead BL; Chao MV J Neurosci; 2004 Mar; 24(11):2742-9. PubMed ID: 15028767 [TBL] [Abstract][Full Text] [Related]
74. TrkA NGF receptor plays a role in the modulation of p75NTR expression. Rankin SL; Guy CS; Mearow KM Neurosci Lett; 2005 Aug; 383(3):305-10. PubMed ID: 15955426 [TBL] [Abstract][Full Text] [Related]
75. Uncoupling of the epidermal growth factor receptor from downstream signal transduction molecules guides the acquired resistance to gefitinib in prostate cancer cells. Festuccia C; Gravina GL; Millimaggi D; Muzi P; Speca S; Ricevuto E; Vicentini C; Bologna M Oncol Rep; 2007 Aug; 18(2):503-11. PubMed ID: 17611677 [TBL] [Abstract][Full Text] [Related]
76. Differences in the surface binding and endocytosis of neurotrophins by p75NTR. Saxena S; Howe CL; Cosgaya JM; Hu M; Weis J; Krüttgen A Mol Cell Neurosci; 2004 Jun; 26(2):292-307. PubMed ID: 15207854 [TBL] [Abstract][Full Text] [Related]
77. p75 neurotrophin receptor and pro-BDNF promote cell survival and migration in clear cell renal cell carcinoma. De la Cruz-Morcillo MA; Berger J; Sánchez-Prieto R; Saada S; Naves T; Guillaudeau A; Perraud A; Sindou P; Lacroix A; Descazeaud A; Lalloué F; Jauberteau MO Oncotarget; 2016 Jun; 7(23):34480-97. PubMed ID: 27120782 [TBL] [Abstract][Full Text] [Related]
78. Raloxifene induces cell death and inhibits proliferation through multiple signaling pathways in prostate cancer cells expressing different levels of estrogen receptor α and β. Rossi V; Bellastella G; De Rosa C; Abbondanza C; Visconti D; Maione L; Chieffi P; Della Ragione F; Prezioso D; De Bellis A; Bellastella A; Sinisi AA J Cell Physiol; 2011 May; 226(5):1334-9. PubMed ID: 20945400 [TBL] [Abstract][Full Text] [Related]
79. Ethanol induces cell cycle arrest and triggers apoptosis via Sp1-dependent p75NTR expression in human neuroblastoma cells. Do H; Park HJ; Sohn EH; Kim BO; Um SH; Kwak JH; Moon EY; Rhee DK; Pyo S Cell Biol Toxicol; 2013 Oct; 29(5):365-80. PubMed ID: 24026251 [TBL] [Abstract][Full Text] [Related]
80. Dryopteris crassirhizoma has anti-cancer effects through both extrinsic and intrinsic apoptotic pathways and G0/G1 phase arrest in human prostate cancer cells. Chang SH; Bae JH; Hong DP; Choi KD; Kim SC; Her E; Kim SH; Kang CD J Ethnopharmacol; 2010 Jul; 130(2):248-54. PubMed ID: 20438825 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]